人工内耳市場は、2024年の28億ドルから、予測期間中に9.2%のCAGRで成長し、2030年には47億3000万ドルに達すると予想されます。人工内耳市場の著名なプレーヤーには、Cochlear Ltd.(オーストラリア)、Sonova(スイス)、MED-EL Medical Electronics(オーストリア)、Zhejiang Nurotron Biotechnology Co.、Ltd.(中国)、Neubio AG(スイス)、TODOC Co.、Ltd.(韓国)、およびShanghai Listent Medical Tech Co.、Ltd.(中国)が含まれます。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources for secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.1.2.5 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.1.1 Presentations of companies and primary interviews
2.2.1.1.2 Primary interviews
2.2.1.1.3 Country-based approach for estimating global market size
2.2.1.1.4 Approach for estimating global market size based on units sold
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.5.1 MARKET ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 COCHLEAR IMPLANTS MARKET OVERVIEW
4.2 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE AND COUNTRY (2023)
4.3 COCHLEAR IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 COCHLEAR IMPLANTS MARKET: REGIONAL MIX (2024-2030)
4.5 COCHLEAR IMPLANTS MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of hearing impairment
5.2.1.2 Growing geriatric population
5.2.1.3 Comprehensive insurance coverage and favorable reimbursement policies
5.2.2 RESTRAINTS
5.2.2.1 High cost of cochlear implants and associated surgeries
5.2.2.2 Surgical risks, procedural complications, and long post-surgery rehabilitation
5.2.3 OPPORTUNITIES
5.2.3.1 Lucrative growth opportunities in emerging economies
5.2.3.2 Technological innovations in cochlear implants
5.2.3.3 Integration with digital health platforms
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals performing ENT procedures
5.2.4.2 Competition from alternative solutions
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021-2023
5.3.2 AVERAGE SELLING PRICE TREND COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021-2023
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.6.1 ROLE IN ECOSYSTEM
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 KEY STAKEHOLDERS & BUYING CRITERIA
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.8.2 KEY BUYING CRITERIA
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY FRAMEWORK
5.9.1.1 North America
5.9.1.1.1 US
5.9.1.1.2 Canada
5.9.1.2 Europe
5.9.1.3 Asia Pacific
5.9.1.3.1 Japan
5.9.1.3.2 China
5.9.1.3.3 India
5.9.1.4 Latin America
5.9.1.4.1 Brazil
5.9.1.4.2 Mexico
5.9.1.5 Middle East
5.9.1.6 Africa
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR HS CODE 902140
5.10.2 EXPORT DATA FOR HS CODE 902140
5.11 PATENT ANALYSIS
5.11.1 LIST OF MAJOR PATENTS
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.14 TECHNOLOGY ANALYSIS
5.14.1 KEY TECHNOLOGIES
5.14.1.1 Electrode-based auditory nerve stimulation
5.14.2 COMPLEMENTARY TECHNOLOGIES
5.14.2.1 Bimodal hearing solutions
5.14.3 ADJACENT TECHNOLOGIES
5.14.3.1 Bone conduction hearing devices
5.15 INVESTMENT & FUNDING SCENARIO
5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET
6 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE
6.1 INTRODUCTION
6.2 COCHLEAR IMPLANT SYSTEMS
6.2.1 INCREASED GERIATRIC POPULATION AND AVAILABILITY OF MEDICAL INSURANCE TO BOOST MARKET GROWTH
6.3 UPGRADES & ACCESSORIES
6.3.1 FOCUS ON TECHNOLOGICAL INNOVATIONS AND DEVICE PERSONALIZATION TO PROPEL MARKET GROWTH
7 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT
7.1 INTRODUCTION
7.2 UNILATERAL IMPLANTS
7.2.1 BETTER INSURANCE COVERAGE TO AID ADOPTION OF UNILATERAL IMPLANTS IN PATIENTS
7.3 BILATERAL IMPLANTS
7.3.1 IMPROVED SOUND LOCALIZATION AND SPEECH COMPREHENSION IN NOISY ENVIRONMENTS AMONG CHILDREN TO AUGMENT GROWTH
8 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE
8.1 INTRODUCTION
8.2 ADULTS
8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS IN GERIATRIC POPULATION TO FUEL ADOPTION OF COCHLEAR IMPLANTS
8.3 PEDIATRICS
8.3.1 EARLY DIAGNOSIS OF HEARING IMPAIRMENTS THROUGH NEWBORN SCREENING PROGRAMS TO SUPPORT MARKET GROWTH
9 COCHLEAR IMPLANTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 INCREASED ACCESS TO ADVANCED DIAGNOSTIC EQUIPMENT AND PRESENCE OF SKILLED SURGICAL TEAMS TO AID MARKET GROWTH
9.3 ENT CLINICS
9.3.1 INCREASING AWARENESS OF ENT-RELATED ISSUES AND GROWING NETWORK OF ADVANCED CLINICS TO AID GROWTH
9.4 OTHER END USERS
10 COCHLEAR IMPLANTS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American cochlear implants market during study period
10.2.3 CANADA
10.2.3.1 Growing geriatric population and rising government health expenditure to propel market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 High incidence of hearing impairment and favorable government health insurance schemes to augment growth
10.3.3 UK
10.3.3.1 Increased prevalence of hearing problems among older adults to boost market growth
10.3.4 FRANCE
10.3.4.1 Need for advanced treatment options and high government healthcare expenditure to spur market adoption
10.3.5 ITALY
10.3.5.1 Well-developed healthcare system with high financial resources to fuel uptake of cochlear implants
10.3.6 SPAIN
10.3.6.1 Long waiting times for ENT appointments and lack of reimbursement to limit market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Advanced healthcare system and rapidly growing geriatric population to support market growth
10.4.3 CHINA
10.4.3.1 Modernization of healthcare facilities and increased patient pool to drive market
10.4.4 INDIA
10.4.4.1 Higher incidence of hearing impairment and increased government funds to propel market growth
10.4.5 AUSTRALIA
10.4.5.1 Increasing number of ENT specialists and rising government funding in public hospitals to support market growth
10.4.6 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Favorable investment scenario from medical device manufacturers to favor market growth
10.5.3 MEXICO
10.5.3.1 Increased FDI and growing presence of key healthcare companies to support market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 FOCUS ON HEALTHCARE SYSTEM MODERNIZATION AND INCREASED GOVERNMENT AWARENESS TO DRIVE MARKET
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.7 GCC COUNTRIES
10.7.1 EMPHASIS ON INFRASTRUCTURAL DEVELOPMENT AND HEALTHCARE ACCESS TO SUPPORT MARKET GROWTH
10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN COCHLEAR IMPLANTS MARKET
11.3 REVENUE ANALYSIS, 2021-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Component type footprint
11.5.5.4 Patient type footprint
11.5.5.5 End-user footprint
11.6 COMPANY VALUATION & FINANCIAL METRICS
11.7 BRAND/PRODUCT COMPARISON
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 COCHLEAR LTD.
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 SONOVA
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Other developments
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 MED-EL MEDICAL ELECTRONICS
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches
12.1.3.3.2 Deals
12.1.3.3.3 Other developments
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.5 NEUBIO AG
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.6 TODOC CO., LTD.
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.7 SHANGHAI LISTENT MEDICAL TECH CO., LTD.
12.1.7.1 Business overview
12.1.7.2 Products offered
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
